Aparna's Story: Redefining Possibilities for Patients with Rare Diseases

Mar 11, 2016 10:00 AM ET

Aparna had only been working as a clinical programmer on Bristol-Myers Squibb’s Global Biometrics Sciences team for six months when five-year-old Tayjus was diagnosed with Duchenne Muscular Dystrophy (DMD). Universal support from managers, co-workers, friends and family has helped her redefine what can be achieved by focusing on one day, and one goal, at a time. Now, 14 years later, Aparna and Tayjus are supporting Bristol-Myers Squibb’s advocacy and clinical development teams—helping them understand the challenges of dealing with rare childhood diseases so they can design more accommodating clinical trials with better access for patients and caregivers.

Join Bristol-Myers Squibb Online:

Website: http://www.bms.com

Twitter: http://www.twitter.com/BMSnews

LinkedIn: https://www.linkedin.com/company/bristol-myers-squibb

YouTube: https://www.youtube.com/channel/UCjFf4oKibYrHae2NZ_GPS6g

Aparna's Story: Redefining Possibilities for Patients with Rare Diseases

More from Bristol Myers Squibb Company

One Community at a Time: Enabling Early Lung Cancer Detection Across the U.S.

Bristol Myers Squibb Promotes Health Equity with 100 Percent of Marketed Products Now Supported by Access Plans

Bristol Myers Squibb's Commitment to Environment, Social and Governance: Our Progress & Aspirational Goals

Bristol Myers Squibb Reaches Major Milestone in Environmental Sustainability

BMS Named 2024 Best Place to Work for Disability Inclusion in US, UK and Brazil by the Disability Equality Index®

Bristol Myers Squibb Named to Dow Jones Sustainability Index North America

ASPIRE: Our Commitment To Address Health Inequities in Low- and Middle-Income Countries

Bristol Myers Squibb Announces 10-Year Strategy to Reach More Patients in Low- and Middle-Income Countries